{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:43:07Z","timestamp":1791409387146,"version":"4.3.3"},"reference-count":61,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,11,15]]},"abstract":"<jats:p>In the present study we analyzed the role of phophatidylinositol-3 kinase (PI-3K) in B chronic lymphocytic leukemia (B-CLL) cells. PI-3K is activated by many stimuli and is linked to several different signaling pathways. We demonstrated that inhibition of PI-3K by a specific inhibitor, LY294002, induced apoptosis in B-CLL cells in vitro. This effect was specific for the inhibition of PI-3K because inhibition of other signaling pathways such as extracellular signaling\u2013regulated kinase (ERK), p38, or p70S6 kinase did not affect spontaneous apoptosis. Furthermore, PI-3K was constitutively activated in freshly isolated B-CLL cells. Corresponding to enhanced apoptosis, LY294002 down-regulated expression of the antiapoptotic proteins X-linked inhibitor of apoptosis protein (XIAP) and Mcl-1. Next, we investigated which factors downstream of PI-3K were activated in B-CLL cells. We demonstrated that protein kinase B\/Akt is expressed in all tested CLL samples but no activation of Akt was detected. In contrast, we observed a constitutive activation of protein kinase C\u03b4 (PKC\u03b4) in freshly isolated B-CLL cells. PKC\u03b4 is linked to PI-3K and is phosphorylated at Thr505 in response to PI-3K activation. We further demonstrated that tyrosine phosphorylation and activity of PKC\u03b4 were dependent on PI-3K activity in B-CLL cells. Inhibition of PKC\u03b4 by the specific inhibitor Rottlerin strikingly enhanced apoptosis. In contrast, peripheral blood B cells of healthy donors were resistant to inhibition of PI-3K or PKC\u03b4. We conclude that activated PI-3K might be important in the pathogenesis of B-CLL, and survival signals might be mediated via PKC\u03b4. Therefore, inhibition of PI-3K or PKC\u03b4 may be an innovative approach to treat B-CLL.<\/jats:p>","DOI":"10.1182\/blood-2002-02-0539","type":"journal-article","created":{"date-parts":[[2002,10,30]],"date-time":"2002-10-30T19:43:16Z","timestamp":1036006996000},"page":"3741-3748","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":213,"title":["Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase C\u03b4"],"prefix":"10.1182","volume":"100","author":[{"given":"Ingo","family":"Ringshausen","sequence":"first","affiliation":[{"name":"From the Third Department of Medicine, Technical University of Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folker","family":"Schneller","sequence":"additional","affiliation":[{"name":"From the Third Department of Medicine, Technical University of Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bogner","sequence":"additional","affiliation":[{"name":"From the Third Department of Medicine, Technical University of Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Hipp","sequence":"additional","affiliation":[{"name":"From the Third Department of Medicine, Technical University of Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Duyster","sequence":"additional","affiliation":[{"name":"From the Third Department of Medicine, Technical University of Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Peschel","sequence":"additional","affiliation":[{"name":"From the Third Department of Medicine, Technical University of Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decker","sequence":"additional","affiliation":[{"name":"From the Third Department of Medicine, Technical University of Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111821270786600_B1","first-page":"306","article-title":"Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.","volume":"85","author":"O'Bien","year":"1995","journal-title":"Blood."},{"key":"2019111821270786600_B2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s001090050351","article-title":"Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival.","volume":"77","author":"Meinhardt","year":"1999","journal-title":"J Mol Med."},{"key":"2019111821270786600_B3","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia.","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med."},{"key":"2019111821270786600_B4","first-page":"11","article-title":"Molecular biology of chronic lymphocytic leukemia.","volume":"25","author":"Reed","year":"1998","journal-title":"Semin Oncol."},{"key":"2019111821270786600_B5","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","article-title":"Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.","volume":"82","author":"Hanada","year":"1993","journal-title":"Blood."},{"key":"2019111821270786600_B6","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","article-title":"Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses.","volume":"91","author":"Kitada","year":"1998","journal-title":"Blood."},{"key":"2019111821270786600_B7","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI119869","article-title":"B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT)1 and STAT3 constitutively phosphorylated on serine residues.","volume":"100","author":"Frank","year":"1997","journal-title":"J Clin Invest."},{"key":"2019111821270786600_B8","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.4049\/jimmunol.164.4.2200","article-title":"Modulation of NF-\u03baB activity and apoptosis in chronic lymphocytic leukemia.","volume":"164","author":"Furman","year":"2000","journal-title":"J Immunol."},{"key":"2019111821270786600_B9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-5793(97)00617-0","article-title":"Using structure to define the function of phosphoinositide 3-kinase family members.","volume":"410","author":"Domin","year":"1997","journal-title":"FEBS Lett."},{"key":"2019111821270786600_B10","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.4049\/jimmunol.165.7.3860","article-title":"Phosphatidylinositol 3-kinase and NF-kappa B\/Rel are at the divergence of CD40 mediated proliferation and survival pathways.","volume":"165","author":"Andjelic","year":"2000","journal-title":"J Immunol."},{"key":"2019111821270786600_B11","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.4049\/jimmunol.156.12.4543","article-title":"Phosphatidylinositol 3-kinase activation in normal human B lymphocytes.","volume":"156","author":"Aagaard-Tillery","year":"1996","journal-title":"J Immunol."},{"key":"2019111821270786600_B12","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1.","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J."},{"key":"2019111821270786600_B13","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1074\/jbc.275.9.6267","article-title":"The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity.","volume":"275","author":"Aoki","year":"2000","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B14","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"AKT2, a putative oncogene encoding a member of a subfamily of protein-serine\/threonine kinase, is amplified in human ovarian carcinomas.","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821270786600_B15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9440(10)61714-2","article-title":"Akt1\/PKB\u03b1 kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.","volume":"159","author":"Sun","year":"2001","journal-title":"Am J Pathol."},{"key":"2019111821270786600_B16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/excr.1999.4690","article-title":"The regulation and activities of the multifunctional serine\/threonine kinase Akt\/PKB.","volume":"253","author":"Kandel","year":"1999","journal-title":"Exp Cell Res."},{"key":"2019111821270786600_B17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/43474","article-title":"NF-kB is a target of Akt in anti-apoptotic PDGF signaling.","volume":"401","author":"Romashkova","year":"1999","journal-title":"Nature."},{"key":"2019111821270786600_B18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.98.1.136","article-title":"A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3K and Akt.","volume":"98","author":"Aoki","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821270786600_B19","doi-asserted-by":"crossref","first-page":"32358","DOI":"10.1016\/S0021-9258(18)31643-0","article-title":"Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3.","volume":"69","author":"Toker","year":"1994","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0161-5890(99)00128-5","article-title":"Activation and tyrosine phosphorylation of proteinkinase C\u03b4 in response to B cell antigen receptor stimulation.","volume":"36","author":"Popoff","year":"1999","journal-title":"Mol Immunol."},{"key":"2019111821270786600_B21","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1074\/jbc.271.24.14514","article-title":"Protein kinase C\u03b4 specifically associates with phosphathidyinositol 3-kinase following cytokine stimulation.","volume":"271","author":"Ettinger","year":"1996","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B22","doi-asserted-by":"crossref","first-page":"20805","DOI":"10.1074\/jbc.274.30.20805","article-title":"Protein kinase C\u03b4 inhibition of S-phase transition in capillary endothelial cell involves the cyclin-dependent kinase inhibitor p27.","volume":"274","author":"Ashton","year":"1999","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B23","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1073\/pnas.89.21.10159","article-title":"Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-\u03b4 subspecies.","volume":"89","author":"Watanabe","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821270786600_B24","doi-asserted-by":"crossref","first-page":"13816","DOI":"10.1074\/jbc.272.21.13816","article-title":"Protein kinase C\u03b4 inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression.","volume":"272","author":"Fukumoto","year":"1997","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/416865a","article-title":"Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C\u03b4.","volume":"416","author":"Miyamoto","year":"2002","journal-title":"Nature."},{"key":"2019111821270786600_B26","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1002\/j.1460-2075.1995.tb00305.x","article-title":"Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.","volume":"14","author":"Emoto","year":"1995","journal-title":"EMBO J."},{"key":"2019111821270786600_B27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726","article-title":"Phosphatidylinositol-3 kinase activity is regulated by BRC\/ABL and is required for growth of Philadelphia chromosome-positive cells.","volume":"86","author":"Skorski","year":"1995","journal-title":"Blood."},{"key":"2019111821270786600_B28","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol-3 kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).","volume":"269","author":"Vlahos","year":"1994","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0145-2126(01)00067-4","article-title":"Homotypic interactions protect chronic lymphocytic leukemia cells from spontaneous death in vitro.","volume":"25","author":"Pettitt","year":"2001","journal-title":"Leuk Res."},{"key":"2019111821270786600_B30","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","article-title":"Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.","volume":"270","author":"Xia","year":"1995","journal-title":"Science."},{"key":"2019111821270786600_B31","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1074\/jbc.275.10.7395","article-title":"The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation and retinoblastoma hyperphosphorylation in interleukin-2 stimulated T-cells independently of p38 MAP kinase.","volume":"275","author":"Lali","year":"2000","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B32","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1073\/pnas.92.17.7686","article-title":"A synthetic inhibitor of the mitogen-activated protein kinase cascade.","volume":"92","author":"Dudley","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821270786600_B33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(97)00323-2","article-title":"The molecular phosphorylation and activation of p70S6kinase.","volume":"410","author":"Pullen","year":"1997","journal-title":"FEBS Lett."},{"key":"2019111821270786600_B34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.271.5250.808","article-title":"Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER.","volume":"271","author":"Pronk","year":"1996","journal-title":"Science."},{"key":"2019111821270786600_B35","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood.V89.9.3378","article-title":"Involvement of CED-3\/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells.","volume":"89","author":"Bellosillo","year":"1997","journal-title":"Blood."},{"key":"2019111821270786600_B36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/40901","article-title":"X-linked IAP is a direct inhibitor of cell death proteases.","volume":"388","author":"Deveraux","year":"1997","journal-title":"Nature."},{"key":"2019111821270786600_B37","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.4049\/jimmunol.163.4.1894","article-title":"The B cell antigen receptor activates the Akt (protein kinase B)\/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.","volume":"163","author":"Gold","year":"1999","journal-title":"J Immunol."},{"key":"2019111821270786600_B38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/bbrc.1994.1199","article-title":"Rottlerin, a novel protein kinase inhibitor.","volume":"199","author":"Gschwendt","year":"1994","journal-title":"Biochem Biophys Res Commun."},{"key":"2019111821270786600_B39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(96)00785-5","article-title":"Inhibition of protein kinase C\u03bc by various inhibitors: differentiation from protein kinase c isoenzymes.","volume":"392","author":"Gschwendt","year":"1996","journal-title":"FEBS Lett."},{"key":"2019111821270786600_B40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V99.1.252","article-title":"Constitutive activation of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.","volume":"99","author":"Benekli","year":"2002","journal-title":"Blood."},{"key":"2019111821270786600_B41","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.leu.2401905","article-title":"Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation.","volume":"14","author":"Tse","year":"2000","journal-title":"Leukemia."},{"key":"2019111821270786600_B42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI12807","article-title":"Therapeutic targeting of MEK\/MAPK signal transduction module in acute myeloid leukemia.","volume":"108","author":"Milella","year":"2001","journal-title":"J Clin Invest."},{"key":"2019111821270786600_B43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.283.5400.393","article-title":"Impaired B cell development and proliferation in absence of phosphoinositide 3 kinase p85\u03b1.","volume":"283","author":"Fruman","year":"1999","journal-title":"Science."},{"key":"2019111821270786600_B44","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1074\/jbc.272.12.7927","article-title":"Interleukin-4 (IL-4) induces phosphatidylinositol 3 kinase (p85) dephosphorylation: implications for the role of SHP-1 in the IL-4-induced signals in human B cells.","volume":"272","author":"Imani","year":"1997","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B45","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood.V99.8.2969","article-title":"Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia.","volume":"99","author":"Barragan","year":"2002","journal-title":"Blood."},{"key":"2019111821270786600_B46","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restaining the phophoinositol-3 kinase\/AKT pathway.","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111821270786600_B47","first-page":"6763","article-title":"The phosphatidylinositol-3 kinase\/Akt pathway in multiple myeloma plasma cells: role in cytokine-dependent survival and proliferation responses.","volume":"60","author":"Tu","year":"2000","journal-title":"Cancer Res."},{"key":"2019111821270786600_B48","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1365-2141.2001.02978.x","article-title":"Autologous plasma activates Akt\/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukemia cells.","volume":"114","author":"Wickremasinghe","year":"2001","journal-title":"Br J Haematol."},{"key":"2019111821270786600_B49","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood.V98.10.3050","article-title":"Survival of leukemic B cells promoted by engagement of antigen receptor.","volume":"98","author":"Bernal","year":"2001","journal-title":"Blood."},{"key":"2019111821270786600_B50","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1126\/science.281.5385.2042","article-title":"Protein kinase C isotypes controlled by phosphoinositide 3 kinase through the protein kinase PDK1.","volume":"281","author":"Good","year":"1998","journal-title":"Science"},{"key":"2019111821270786600_B51","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1074\/jbc.272.10.6805","article-title":"Phosphorylation of protein kinase C\u03b4 (PKC\u03b4) at threonine 505 is not a prerequisite for enzymatic activity: expression of rat PKCdelta and an alanine 505 mutant in bacteria in a functional form.","volume":"272","author":"Stempka","year":"1997","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-5793(94)00514-1","article-title":"Tyrosine phosphorylation and stimulation of protein kinase C\u03b4 from porcine spleen by src in vitro: dependence on the activated state of protein kinase C\u03b4.","volume":"347","author":"Gschwendt","year":"1994","journal-title":"FEBS Lett."},{"key":"2019111821270786600_B53","doi-asserted-by":"crossref","first-page":"24392","DOI":"10.1074\/jbc.274.34.24392","article-title":"Protein kinase C\u03b4 associates with phosphorylates Stat3 in an interleukin-6 dependent manner.","volume":"274","author":"Jain","year":"1999","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B54","doi-asserted-by":"crossref","first-page":"19746","DOI":"10.1074\/jbc.M100234200","article-title":"NF-\u03baB activation in tumor necrosis factor \u03b1-stimulated neutrophils is mediated by protein kinase C\u03b4: correlation to nuclear Ikappa Balpha.","volume":"276","author":"Vancurova","year":"2001","journal-title":"J Biol Chem."},{"key":"2019111821270786600_B55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-4827(92)90393-M","article-title":"Induction of apoptosis in CLL and its prevention by phorbol ester.","volume":"198","author":"Forbes","year":"1992","journal-title":"Exp Cell Res."},{"key":"2019111821270786600_B56","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.1999.01642.x","article-title":"Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-CLL.","volume":"106","author":"Kitada","year":"1999","journal-title":"Br J Haematol."},{"key":"2019111821270786600_B57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood.V96.2.393","article-title":"Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-CLL.","volume":"96","author":"Kitada","year":"2000","journal-title":"Blood."},{"key":"2019111821270786600_B58","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood.V98.7.2039","article-title":"Chronic myeloid leukemia: current treatment options.","volume":"98","author":"Goldman","year":"2001","journal-title":"Blood."},{"key":"2019111821270786600_B59","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2001.19.5.1485","article-title":"Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.","volume":"19","author":"Propper","year":"2001","journal-title":"J Clin Oncol."},{"key":"2019111821270786600_B60","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ijc.2910430519","article-title":"A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity.","volume":"43","author":"Meyer","year":"1989","journal-title":"Int J Cancer."},{"key":"2019111821270786600_B61","first-page":"825","article-title":"Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.","volume":"6","author":"Varterasian","year":"2000","journal-title":"Clin Cancer Res."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/10\/3741\/1253506\/h82202003741.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/10\/3741\/1253506\/h82202003741.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T19:38:08Z","timestamp":1682365088000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/10\/3741\/106361\/Constitutively-activated-phosphatidylinositol3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,15]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-02-0539","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11,15]]}}}